Table 1.
Total (n = 69) | Clinical HCM (n = 55) | Subclinical HCM mutation carriers (n = 14) | |
---|---|---|---|
Age (years) | 51 ± 16 | 54 ± 16 | 40 ± 10 |
Male | 38 (55) | 34 (62) | 4 (29) |
Pathogenic mutation present | 37 (54) | 23 (42) | 14 (100) |
NYHA class I/II | 67 (97) | 53 (96) | 14 (100) |
NYHA class III | 2 (3) | 2 (4) | – |
Data are presented as mean ± standard deviation or numbers (percentages). HCM hypertrophic cardiomyopathy, NYHA New York Heart Association.